Terms: = Pancreatic cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
268 results:
1. Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma.
Rupp L; Dietsche I; Kießler M; Sommer U; Muckenhuber A; Steiger K; van Eijck CWF; Richter L; Istvanffy R; Jäger C; Friess H; van Eijck CHJ; Demir IE; Reyes CM; Schmitz M
Front Immunol; 2024; 15():1378190. PubMed ID: 38629072
[TBL] [Abstract] [Full Text] [Related]
2. Decoding the Versatile Landscape of Autophagic Protein VMP1 in cancer: A Comprehensive Review across Tissue Types and Regulatory Mechanisms.
Renna FJ; Gonzalez CD; Vaccaro MI
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612567
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Preoperative Chemotherapy for Advanced Gastric cancer, Laparoscopic Total Gastrectomy, pancreaticoduodenectomy, and Para-Aortic Lymph Node Dissection].
Fukuda K; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Ikenaga M; Kawase T; Shimizu J; Imamura H; Dono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1438-1440. PubMed ID: 38303300
[TBL] [Abstract] [Full Text] [Related]
4. Therapy-induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression.
Abu-Humaidan AH; Ismail MA; Ahmad FM; Al Shboul S; Barham R; Tadros JS; Alhesa A; El-Sadoni M; Alotaibi MR; Ababneh NA; Saleh T
Immunol Cell Biol; 2024 Apr; 102(4):240-255. PubMed ID: 38265162
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
7. Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-box
Zhang H; Xia P; Yang Z; Liu J; Zhu Y; Huang Z; Zhang Z; Yuan Y
Clin Transl Med; 2023 Oct; 13(10):e1443. PubMed ID: 37837399
[TBL] [Abstract] [Full Text] [Related]
8. Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer.
Xia L; Nie T; Lu F; Huang L; Shi X; Ren D; Lu J; Li X; Xu T; Cui B; Wang Q; Gao G; Yang Q
Autophagy; 2024 Mar; 20(3):505-524. PubMed ID: 37772772
[TBL] [Abstract] [Full Text] [Related]
9. Hydrogen Peroxide Mediates Pharmacological Ascorbate Induced Radio-Sensitization of pancreatic cancer Cells by Enhancing G2-accumulation and Reducing Cyclin B1 Protein Levels.
O'Leary BR; Kalen AL; Pope AN; Goswami PC; Cullen JJ
Radiat Res; 2023 Nov; 200(5):444-455. PubMed ID: 37758045
[TBL] [Abstract] [Full Text] [Related]
10. Chronic expanding hematoma of the liver: a case report and review of the literature.
Shimagaki T; Sugimachi K; Mano Y; Tomino T; Onishi E; Taguchi K; Morita M; Toh Y
Clin J Gastroenterol; 2024 Feb; 17(1):93-99. PubMed ID: 37751079
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
Chen Q; Fu Y; Liu X; Wang P; Dai S; Zhu F; Liu T; Xu W; Wu J
Mol Carcinog; 2023 Dec; 62(12):1947-1959. PubMed ID: 37642304
[TBL] [Abstract] [Full Text] [Related]
12. High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma.
Zhou Y; Gu Q; Zhu L; Zhang S; Wu H; Pu X; Jiang C; Chen J
Cell Prolif; 2023 Dec; 56(12):e13513. PubMed ID: 37401015
[TBL] [Abstract] [Full Text] [Related]
13. Role of Immune Microenvironment in pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?
De Simoni O; Dal Santo L; Scarpa M; Munari G; Spolverato YC; Scapinello A; Lonardi S; Soldà C; Bergamo F; Fantin A; Bardini R; Pilati P; Fassan M; Gruppo M
Curr Oncol; 2023 Jun; 30(6):5515-5528. PubMed ID: 37366900
[TBL] [Abstract] [Full Text] [Related]
14. MHC class I loss is associated with biliary/progenitor cell features and "cold" tumor-immune microenvironment in hepatocellular carcinoma.
Shigematsu Y; Amori G; Tanaka K; Kitahama K; Kanda H; Takahashi Y; Takazawa Y; Takeuchi K; Inamura K
Virchows Arch; 2023 Aug; 483(2):177-186. PubMed ID: 37306724
[TBL] [Abstract] [Full Text] [Related]
15. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
16. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.
Kotsiliti E; Leone V; Schuehle S; Govaere O; Li H; Wolf MJ; Horvatic H; Bierwirth S; Hundertmark J; Inverso D; Zizmare L; Sarusi-Portuguez A; Gupta R; O'Connor T; Giannou AD; Shiri AM; Schlesinger Y; Beccaria MG; Rennert C; Pfister D; Öllinger R; Gadjalova I; Ramadori P; Rahbari M; Rahbari N; Healy ME; Fernández-Vaquero M; Yahoo N; Janzen J; Singh I; Fan C; Liu X; Rau M; Feuchtenberger M; Schwaneck E; Wallace SJ; Cockell S; Wilson-Kanamori J; Ramachandran P; Kho C; Kendall TJ; Leblond AL; Keppler SJ; Bielecki P; Steiger K; Hofmann M; Rippe K; Zitzelsberger H; Weber A; Malek N; Luedde T; Vucur M; Augustin HG; Flavell R; Parnas O; Rad R; Pabst O; Henderson NC; Huber S; Macpherson A; Knolle P; Claassen M; Geier A; Trautwein C; Unger K; Elinav E; Waisman A; Abdullah Z; Haller D; Tacke F; Anstee QM; Heikenwalder M
J Hepatol; 2023 Aug; 79(2):296-313. PubMed ID: 37224925
[TBL] [Abstract] [Full Text] [Related]
17. A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer.
Liu F; Xiang Q; Luo Y; Luo Y; Luo W; Xie Q; Fan J; Ran H; Wang Z; Sun Y
J Nanobiotechnology; 2023 May; 21(1):165. PubMed ID: 37221521
[TBL] [Abstract] [Full Text] [Related]
18. Characterization and digital spatial deconvolution of the immune microenvironment of intraductal oncocytic papillary neoplasms (IOPN) of the pancreas.
Pea A; Paolino G; Martelli F; Bariani E; Piccoli P; Sereni E; Salvia R; Lawlor RT; Cheng L; Chang D; Scarpa A; Luchini C
Virchows Arch; 2023 Aug; 483(2):157-165. PubMed ID: 37086293
[TBL] [Abstract] [Full Text] [Related]
19. Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal cancer Liver Metastasis.
Zhang D; Chen Z; Zhang L; Qian X; Huang X; Zheng Z; Pan W
J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939250
[TBL] [Abstract] [Full Text] [Related]
20. Follicular pancreatitis: Case report and literature review.
Lee WS; Kim KH; Noh MG; Joo YE
Medicine (Baltimore); 2023 Feb; 102(5):e32837. PubMed ID: 36749228
[TBL] [Abstract] [Full Text] [Related]
[Next]
